Drawing for GENOSPHERE

USPTO serial 99405384

GENOSPHERE

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
NKOJO, RHODA K
Law office
TMO LAW OFFICE 117

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENOSPHERE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DEVIN LEE JOSEPH LOOIJEN

400 S El Camino RealSTE 300San Mateo, CA 94402

Goods and services

ClassDescriptionStatusFirst use
035Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Collecting and analyzing claims data from healthcare organizations for business purposes; Recruitment and placement of volunteers in the field of clinical trials; Data processing services in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomicsACTIVESep 10, 2025
042Scientific research; Medical research; Pharmaceutical research services; Biomedical research services; Medical research services; Scientific research consulting; Scientific research consultancy; Providing scientific research information; Blood analysis for scientific research purposes; DNA analysis for scientific research purposes; DNA analysis services for scientific research purposes; Scientific research in the field of genetics; Research in the field of genetic diseases; Blood analysis services for scientific research purposes; Providing information about medical research via a website; Genetic testing for scientific research purposes; Providing medical research information in the field of genetics; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data exploration; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for creating complex data science analyses; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing scientific research information in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Scientific research in the field of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomics; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for enhancing research by facilitating analysis, curation, and assembly of patient cohorts for study, all pertaining to healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, and pharmacogenomicsACTIVESep 10, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 28, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 28, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 28, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Feb 28, 2026CNSLSUSPENSION LETTER WRITTEN—
Feb 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2026DOCKASSIGNED TO EXAMINER—
Feb 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 22, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance